Molecular-targeted therapy for cancer.
- Author:
Bing DONG
1
;
Yi-Min ZHU
Author Information
1. Nanobiomedicine Division, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou, Jiangsu 215125, P. R. China.
- Publication Type:Journal Article
- MeSH:
Angiogenesis Inhibitors;
therapeutic use;
Antibodies, Monoclonal;
therapeutic use;
Antineoplastic Agents;
therapeutic use;
Humans;
Molecular Targeted Therapy;
methods;
Neoplasms;
drug therapy;
metabolism;
Neovascularization, Pathologic;
drug therapy
- From:Chinese Journal of Cancer
2010;29(3):340-345
- CountryChina
- Language:English
-
Abstract:
Molecular-targeted therapy is a newly developed approach for cancer therapy. With the advantages of lower side effects and higher performance, this approach has become a critical focus of cancer research. There are various molecules that can be treated as therapeutic targets for cancer. These molecules are located in different compartments of cancer cells, such as the cell membrane, cytoplasm, nuclei, and extracellular matrix. In this review, we mainly discussed the current progress in molecular-targeted therapy for cancers and the development of new drugs in this field.
